A pilot randomized clinical safety study of sonothrombolysis augmentation with ultrasound-activated perflutren-lipid microspheres for acute ischemic stroke

被引:131
作者
Alexandrov, Andrei V. [1 ,2 ,3 ]
Mikulik, Robert [2 ]
Ribo, Marc [2 ]
Sharma, Vijay K. [3 ]
Lao, Annabelle Y. [3 ]
Tsivgoulis, Georgios [1 ,3 ]
Sugg, Rebecca M. [1 ,2 ]
Barreto, Andrew [2 ]
Sierzenski, Paul [4 ]
Malkoff, Marc D. [3 ]
Grotta, James C. [2 ]
机构
[1] Univ Alabama Birmingham, RWUH M226, Comprehens Stroke Ctr Neurol, Sch Med, Birmingham, AL 35249 USA
[2] Univ Texas Houston, Sch Med, Stroke Program, Houston, TX USA
[3] Barrow Neurol Inst, Neurosonol & Stroke Program, Phoenix, AZ 85013 USA
[4] Christiana Healthcare, Wilmington, DE USA
关键词
microspheres; thrombolysis; stroke; occlusion; transcranial Doppler;
D O I
10.1161/STROKEAHA.107.505727
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and Purpose-Ultrasound transiently expands perflutren-lipid microspheres (mu S), transmitting energy momentum to surrounding fluids. We report a pilot safety/feasibility study of ultrasound-activated mu S with systemic tissue plasminogen activator (tPA). Methods-Stroke subjects treated within 3 hours had abnormal Thrombolysis in Brain Ischemia (TIBI) residual flow grades 0 to 3 before tPA on transcranial Doppler (TCD). Randomization included Controls (tPA + TCD) or Target (tPA = TCD = 2.8 mL mu S). The primary safety end point was symptomatic intracranial hemorrhage (sICH) with worsening by >= 4 NIHSS points within 72 hours. Results-Fifteen subjects were randomized 3: 1 to Target, n = 12 or Control, n = 3. After treatment, asymptomatic ICH occurred in 3 Target and 1 Control, and sICH was not seen in any study subject. mu S reached MCA occlusions in all Target subjects at velocities higher than surrounding residual red blood cell flow: 39.8 +/- 11.3 vs 28.8 +/- 13.8 cm/s, P<0.001. In 75% of subjects, mu S permeated to areas with no pretreatment residual flow, and in 83% residual flow velocity improved at a median of 30 minutes from start of mu S infusion (range 30 s to 120 minutes) by a median of 17 cm/s (118% above pretreatment values). To provide perspective, current study recanalization rates were compared with the tPA control arm of the CLOTBUST trial: complete recanalization 50% versus 18%, partial 33% versus 33%, none 17% versus 49%, P = 0.028. At 2 hours, sustained complete recanalization was 42% versus 13%, P = 0.003, and NIHSS scores 0 to 3 were reached by 17% versus 8%, P = 0.456. Conclusions-Perflutren mu S reached and permeated beyond intracranial occlusions with no increase in sICH after systemic thrombolysis suggesting feasibility of further mu S dose-escalation studies and development of drug delivery to tissues with compromised perfusion.
引用
收藏
页码:1464 / 1469
页数:6
相关论文
共 23 条
  • [1] Intravenous tissue-type plasminogen activator for treatment of acute stroke - The standard treatment with alteplase to reverse stroke (STARS) study
    Albers, GW
    Bates, VE
    Clark, WM
    Bell, R
    Verro, P
    Hamilton, SA
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (09): : 1145 - 1150
  • [2] Ultrasound-enhanced systemic thrombolysis for acute ischemic stroke
    Alexandrov, AV
    Molina, CA
    Grotta, JC
    Garami, Z
    Ford, SR
    Alvarez-Sabin, J
    Montaner, J
    Saqqur, M
    Demchuk, AM
    Moye, LA
    Hill, MD
    Wojner, AW
    Al-Senani, F
    Burgin, S
    Calleja, S
    Campbell, M
    Chen, CI
    Chernyshev, O
    Choi, J
    El-Mitwalli, A
    Felberg, R
    Ford, S
    Garami, Z
    Irr, W
    Grotta, J
    Hall, C
    Iguchi, Y
    Ireland, J
    Labiche, L
    Malkoff, M
    Morgenstern, L
    Noser, E
    Okon, N
    Piriyawat, P
    Robinson, D
    Shaltoni, H
    Shaw, S
    Uchino, K
    Yatsu, F
    Alvarez-Sabín, J
    Arenillas, JF
    Huertas, R
    Molina, C
    Montaner, J
    Ribó, M
    Rubiera, M
    Santamarina, E
    Saqqur, M
    Alchtar, N
    O'Rourke, F
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (21) : 2170 - 2178
  • [3] Yield of transcranial Doppler in acute cerebral ischemia
    Alexandrov, AV
    Demchuk, AM
    Wein, TH
    Grotta, JC
    [J]. STROKE, 1999, 30 (08) : 1604 - 1609
  • [4] BLINC A, 1994, THROMB HAEMOSTASIS, V71, P230
  • [5] Burns P N, 1994, Radiol Med, V87, P71
  • [6] Transcranial low-frequency ultrasound-mediated thrombolysis in brain ischemia - Increased risk of hemorrhage with combined ultrasound and tissue plasminogen activator - Results of a phase II clinical trial
    Daffertshofer, M
    Gass, A
    Ringleb, P
    Sitzer, M
    Sliwka, U
    Els, T
    Sedlaczek, O
    Koroshetz, WJ
    Hennerici, MG
    [J]. STROKE, 2005, 36 (07) : 1441 - 1446
  • [7] PRINCIPLES AND RECENT DEVELOPMENTS IN ULTRASOUND CONTRAST AGENTS
    DEJONG, N
    TENCATE, FJ
    LANCEE, CT
    ROELANDT, JRTC
    BOM, N
    [J]. ULTRASONICS, 1991, 29 (04) : 324 - 330
  • [8] Thrombolysis in Brain Ischemia (TIBI) transcranial Doppler flow grades predict clinical severity, early recovery, and mortality in patients treated with intravenous tissue plasminogen activator
    Demchuk, AM
    Burgin, WS
    Christou, I
    Felberg, RA
    Barber, PA
    Hill, MD
    Alexandrov, AV
    [J]. STROKE, 2001, 32 (01) : 89 - 93
  • [9] Specific transcranial Doppler flow findings related to the presence and site of arterial occlusion
    Demchuk, AM
    Christou, I
    Wein, TH
    Felberg, RA
    Malkoff, M
    Grotta, JC
    Alexandrov, AV
    [J]. STROKE, 2000, 31 (01) : 140 - 146
  • [10] Effect of ultrasound on thrombolysis of middle cerebral artery occlusion
    Eggers, J
    Koch, B
    Meyer, K
    König, I
    Seidel, G
    [J]. ANNALS OF NEUROLOGY, 2003, 53 (06) : 797 - 800